Jonathan Javitt
Analyst
Chief Scientist
Chairman
NRX Pharmaceuticals, Inc. (NRXP)Board Member
NRX Pharmaceuticals, Inc. (NRXP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Chief Scientist
Analyst
Source not stated
Current -
Current
-
Current
-
Start not stated–2022-03-08
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | NRX Pharmaceuticals, Inc. (NRXP) | Chairman and Chief Scientist | $602,755 | $630,198 |
| 2022 | NRX Pharmaceuticals, Inc. (NRXP) | Chairman and Chief Scientist | $867,446 | $873,696 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.